Authors:
Address: Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Journal:

Publication:

abstract

Rodents are natural reservoirs for a variety of species of Borrelia that cause relapsing fever (RF) in humans. The murine model of this disease recapitulates many of the clinical manifestations of the human disease and has revealed that T cell-independent antibody responses are required to resolve the bacteremic episodes. However, it is not clear whether such protective humoral responses are mounted in humans. We examined Borrelia hermsii infection in human hematopoietic stem cell-engrafted nonobese diabetic/SCID/IL-2Rγ(null) mice: "human immune system mice" (HISmice). Infection of these mice, which are severely deficient in lymphoid and myeloid compartments, with B. hermsii resulted in persistent bacteremia. In contrast, this infection in HISmice resulted in recurrent episodes of bacteremia, the hallmark of RF. The resolution of the primary episode of bacteremia was concurrent with the generation of B. hermsii-specific human IgM. Remarkably, HISmice generated antibody responses to the B. hermsii outer-membrane protein Factor H binding protein A. Sera from humans infected by B. hermsii have a similar reactivity, and studies in mice have shown that this response is generated by the B1b cell subset. HISmice contain several B-cell subsets, including those with the phenotype CD20(+)CD27(+)CD43(+)CD70(-), a proposed human equivalent of mouse B1 cells. Reduction of B cells by administration of anti-human CD20 antibody resulted in diminished anti-B. hermsii responses and persistent bacteremia in HISmice. These data indicate that analysis of B. hermsii infection in HISmice will serve as a model in which to study the cellular and molecular mechanisms involved in controlling human RF.

Related Articles
The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes.
J Immunol. 2003
The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes.
Alugupalli KR, Gerstein RM, Chen J, Szomolanyi-Tsuda E, Woodland RT, Leong JM. J Immunol. 2003 Apr 1; 170(7):3819-27.
Toll-like receptor 2 deficiency results in impaired antibody responses and septic shock during Borrelia hermsii infection.
Infect Immun. 2010
Toll-like receptor 2 deficiency results in impaired antibody responses and septic shock during Borrelia hermsii infection.
Dickinson GS, Piccone H, Sun G, Lien E, Gatto L, Alugupalli KR. Infect Immun. 2010 Nov; 78(11):4579-88. Epub 2010 Aug 9.
Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d.
J Immunol. 2005
Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d.
Belperron AA, Dailey CM, Bockenstedt LK. J Immunol. 2005 May 1; 174(9):5681-6.
Review B1b lymphocyte-derived antibodies control Borrelia hermsii independent of Fcα/μ receptor and in the absence of host cell contact.
Immunol Res. 2011
Review B1b lymphocyte-derived antibodies control Borrelia hermsii independent of Fcα/μ receptor and in the absence of host cell contact.
Colombo MJ, Abraham D, Shibuya A, Alugupalli KR. Immunol Res. 2011 Dec; 51(2-3):249-56.
Review The mammalian host response to borrelia infection.
Wien Klin Wochenschr. 2006
Review The mammalian host response to borrelia infection.
Cadavid D. Wien Klin Wochenschr. 2006 Nov; 118(21-22):653-8.

To top • Home

---

Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer • webmaster